L impatto dell imaging sulla definizione della strategia terapeutica

Similar documents
Disclosure. Acknowledgement. What is the Best Workup for Rectal Cancer Staging: US/MRI/PET? Rectal cancer imaging. None

RECTAL CARCINOMA: A DISTANCE APPROACH. Stephanie Nougaret

Carcinoma del retto: Highlights

Radiotherapy for rectal cancer. Karin Haustermans Department of Radiation Oncology

RECTAL CANCER CLINICAL CASE PRESENTATION

Imaging in gastric cancer

Rectal cancer management: a team sport The role of radiology and the multidisciplinary conference

Adjuvant Chemotherapy for Rectal Cancer: Are we making progress?

IMAGING GUIDELINES - COLORECTAL CANCER

Mini J.Elnaggar M.D. Radiation Oncology Ochsner Medical Center 9/23/2016. Background

Rectal Cancer: Classic Hits

COLORECTAL CARCINOMA

Role of MRI for Staging Rectal Cancer

COLORECTAL CANCER STAGING in 2010

Rob Glynne-Jones Mount Vernon Cancer Centre

Colorectal Pathway Board (Clinical Subgroup): Imaging Guidelines September 2015

Rectal Cancer : Curative treatment without surgery

UCL. Rectum Adenocarcinoma. Quality of conformal radiotherapy Impact for the surgeon P. Scalliet & K. Haustermans

Early Rectal Cancer Surgical options Organ Preservation? Chinna Reddy Colorectal Surgeon Western General, Edinburgh

Rectal Cancer Update 2008 The Last 5 cm. Consensus Building

Radiotherapy for Rectal Cancer. Kevin Palumbo Adelaide Radiotherapy Centre

Local staging of colon cancer: the current role of CT

MRI in staging of rectal carcinoma

Cover Page. The handle holds various files of this Leiden University dissertation.

Case Scenario 1. The patient has now completed his neoadjuvant chemoradiation and has been cleared for surgery.

Handling & Grossing of Colo-rectal Specimens for Tumours. for Medical Officers in Pathology

ADJUVANT CHEMOTHERAPY...

CT PET SCANNING for GIT Malignancies A clinician s perspective

Staging Colorectal Cancer

Pathohistological Assessment of the Circular Margin of Resection During Total Mesorectal Excision, Conducted on The Malignant Formations of the Rectum

COLON AND RECTAL CANCER

is time consuming and expensive. An intra-operative assessment is not going to be helpful if there is no more tissue that can be taken to improve the

CHAPTER 7 Concluding remarks and implications for further research

State of the art: Standard(s) of radio/chemotherapy for rectal cancer

Preoperative adjuvant radiotherapy

11/21/13 CEA: 1.7 WNL

Staging of rectal cancer on MRI: What the surgeons want to know.

PATHOLOGY GROUP GUIDELINES FOR THE EXAMINATION AND REPORTING OF COLORECTAL CANCER SPECIMENS

LOINC. Clinical information. RCPA code. Record if different to report header Operating surgeon name and contact details. Absent.

Case Conference. Craig Morgenthal Department of Surgery Long Island College Hospital

Disclosures. Outline. What IS tumor budding?? Tumor Budding in Colorectal Carcinoma: What, Why, and How. I have nothing to disclose

Colorectal Cancer Structured Pathology Reporting Proforma DD MM YYYY

Meta analysis in Rectal Cancer

Treatment of Locally Advanced Rectal Cancer: Current Concepts

Dr. Anat Ravid Surgical Oncology Lead Erie St. Clair Regional Cancer Program May 1, 2014

8. The polyp in the illustration can be described as (circle all that apply) a. Exophytic b. Pedunculated c. Sessile d. Frank

MRI Rectal Staging Template Revision Summary

Colorectal Cancer and FDG PET/CT

Current Issues and Controversies in the Management of Rectal Cancer

COLON AND RECTAL CANCER

Dr Sneha Shah Tata Memorial Hospital, Mumbai.

Surgical Margins in Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma

Local Excision of Rectal Cancer Techniques and Outcomes

Locally advanced head and neck cancer

Opportunity for palliative care Research

Intended for use by Clinicians and Health Care Providers involved in the Management or Referral of adult patients with pancreatic

Pancreatic Cancer and Radiation Therapy

Case Scenario year-old white male presented to personal physician with dyspepsia with reflux.

Early colorectal cancer Quality and rules for a good pathology report Histoprognostic factors

Alison Douglass Gillian Lieberman, MD. November. Colon Cancer. Alison Douglass, Harvard Medical School Year III Gillian Lieberman, MD

Rob Glynne-Jones Mount Vernon Cancer Centre

Rectal Cancer Cookbook Update. A. JOURET-MOURIN with the collaboration of A Hoorens,P Demetter, G De Hertogh,C Cuvelier and C Sempoux

CREATE Trial Proposal: Survey of current practice and potential trial participation

Ultrasound for Pre-operative Evaluation of Well Differentiated Thyroid Cancer

Pre-operative Ultrasound of Lymph Nodes in Thyroid Cancer

Advances in Imaging Technology In The Management of Colorectal Cancer

4/22/2010. Hakan Korkmaz, MD Assoc. Prof. of Otolaryngology Ankara Dıșkapı Training Hospital-Turkey.

16/09/2015. ACOSOG Z011 changing practice. Presentation outline. Nodal mets #1 prognostic tool. Less surgery no change in oncologic outcomes

The role of chemoradiotherapy in GE junction and gastric cancer. Karin Haustermans

MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER

SMALL BOWEL ADENOCARCINOMA. Dr. C. Jeske

Controversies in Breast Pathology ELENA PROVENZANO ADDENBROOKES HOSPITAL, CAMBRIDGE

Breast Surgery When Less is More and More is Less. E MacIntosh, MD June 6, 2015

11/09/2014. Update Management of Rectal Cancer. Outline. I have no disclosures

Gastric Cancer Staging AJCC eighth edition. Duncan McLeod Westmead Hospital, NSW

Oral cavity cancer Post-operative treatment

Innovations in Rectal Cancer Surgery

Loco-Regional Management After Neoadjuvant Chemotherapy

Prostate Case Scenario 1

Pre- Versus Post-operative Radiotherapy

Introduction. Approximately 40,000 patients are diagnosed with rectal. Original Article

[A RESEARCH COORDINATOR S GUIDE]

Laparoscopic Resection Of Colon & Rectal Cancers. R Sim Centre for Advanced Laparoscopic Surgery, TTSH

Diagnosis and management of retroperitoneal sarcoma

Case Scenario 1 Worksheet. Primary Site C44.4 Morphology 8743/3 Laterality 0 Stage/ Prognostic Factors

Modalities of Radiation

Tumours of the Oesophagus & Gastro-Oesophageal Junction Histopathology Reporting Proforma

malignant polyp Daily Challenges in Digestive Endoscopy for Endoscopists and Endoscopy Nurses BSGIE Annual Meeting 18/09/2014 Mechelen

Neoadjuvant treatment Evolution and Current Status

EVERYTHING YOU WANTED TO KNOW ABOUT. Robin Billet, MA, CTR, Head & Neck CTAP Member May 9, 2013

Surgical Management of Pancreatic Cancer

The Role Of The Post-CRT MRI In Assessing Response

Loco-Regional Management After Neoadjuvant Chemotherapy

Esophageal cancer: Biology, natural history, staging and therapeutic options

State-of-the-art of surgery for resectable primary tumors

Index. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type.

Index. Surg Oncol Clin N Am 14 (2005) Note: Page numbers of article titles are in boldface type.

Tristate Lung Meeting 2014 Pro-Con Debate: Surgery has no role in the management of certain subsets of N2 disease

Transcription:

GISCoR L impatto dell imaging sulla definizione della strategia terapeutica M. Galeandro U.C. Radioterapia Oncologica ASMN-IRCCS Reggio Emilia 14 Novembre 2014

Rectal Cancer TNM AJCC-7 th edition 2010

Rectal cancer staging is based on 2 principles: To define the pertinent anatomy, allowing for surgical planning To allow prognostic stage grouping To select a tailored therapeutic approach in relation to the risk of local or distant recurrence To reduce overall morbidity from potential overtreatment, while allowing aggressive treatment of high-risk patients Therefore, the aim of preoperative staging is to accurately differentiate between good and poor prognosis tumors

IL BUONO ct1-2 AND cn0 No preop RT IL BRUTTO IL CATTIVO ct3, expected CRM or any suspicious node not threatening the surgical margin expected close (<1mm) or CRM+ rectal cancer or tumor encroaching onto sphincterial plane or elevator involvement Short course RT Combined-modality therapy consisting of surgery, radiation therapy, and chemotherapy is recommended for the majority of patients with stage II or stage III Long course CRT BRUTTO/CATTIVO borderline rectal cancer appearing unresectable or borderline resectable Long course CRT

Compared to postop (C)RT, the preop (C)RT is associated with a superior overall compliance rate, an improved rate of local control, reduced toxicity, an increased rate of sphincter preservation (?) Do not offer preop (C)RT solely to facilitate sphincter-saving surgery Main disadvantage: possibility of overtreating early-stage tumors Even with improvements in preoperative staging techniques, the risk of over or under-staging disease has not been eliminated Post-op CRT is recommended when stage I rectal cancer is upstaged to stage II or III after pathologic review of the surgical specimen

Selection of Patients for Preop Treatment Based on Prognostic Features The assessment of morphologic features by histopathologists in the resected rectal specimen remains the most robust method of prognostic stratification These features include assessment of 1. depth of spread (> o 5mm) 2. circumferential resection margin (CRM) 3. extramural vascular invasion (EMVi) 4. nodal status 5. peritoneal perforation

Modalities of Local Staging Intraluminal Endoscopic Ultrasound (EUS) Very accurate for early-stage low tumors (T1 and T2), with a sensitivity of 94% and specificity of 86% but performs less well in cases of advanced rectal cancer (Garcia-Aguilar 2000) EUS can detect lymph nodes >5 mm in size; but an estimated 50% of metastatic lymph node associated with rectal cancer is smaller than 5 mm, so the sensitivity of EUS is limited The mesorectum and the peritoneum cannot be visualized by EUS, so the CRM status and degree of peritoneal involevment cannot be determined None information about extramural venous invasion

CT Scanning for M MRI

Selection of Patients for Preop Treatment Based on Prognostic Features The assessment of morphologic features by histopathologists in the resected rectal specimen remains the most robust method of prognostic stratification These features include assessment of 1. depth of spread (> o 5mm) 2. circumferential resection margin (CRM) 3. extramural vascular invasion (EMVi) 4. nodal status 1. Location and sphinteric infiltration

Extramural tumor depth study # pts stage treatments results MERCURY Radiology 2007 679 any stage various approaches MR is accurate to measure Extramural depth MRI is equivalent to histology in measurement of extramural depth This is independent of lymph node involvement T with extension into the mesorectum >5 mm have lower 5 y survival Sensitivities 71-91% Specificities of 78-100% MRI imaging can enable accurate preoperative prognostication

Extramural tumor depth Since the maximal extramural depth of spread, from the outer edge of muscularis propria to the outermost edge of the tumour, correlates with cancer specific survival, clinical stage T3 rectal cancers should be subclassified as depicted in table

Circumferential resection margin If the MRF is involved or if the tumour extends to a point within 1 mm from the MRF, there is a clear risk that CRM will be involved after surgery if only a TME is performed

Circumferential resection margin Since Patients pre-op with RT-CRT a CRM clearance is more of efficient less than and 1 and less 5 mm toxic have than a worse post-op 5- therapy, y survival it has than become patients increasingly with a larger important margin to evaluate the risk of MRF+ before the surgery For preoperative staging of rectal cancer, the best cut-off distance Of for the predicting preoperative MRF involvement features, using the relationship MRI is 1 mm of the tumour to the MRF has emerged as one of the most powerful predictors of outcome in terms of local recurrence, development of DM, survival

Extramural venous invasion(emvi) Presence of malignant cells within the endothelial blood vessels beyond the muscularis propria It can occur in up to 50% of rectal cancer patients EMVI can be identified pre-operatively on MRI with reasonable accuracy EMVI is a poor prognostic factor for overall survival and local recurrence The poor prognostic value on overall survival and local recurrence of EMVI is independent of tumour stage

Lymph node status 15-42% of pts have small <5 mm mesorectal patologic lymph nodes Identifying nodal disease is still a diagnostic problem Although lymph node size is not accurate for defining N metastases, nodes of >8 mm are suspicious for nodal involvement on CT, MRI and EUS The most reliable method of positively identifying nodal metastases is based on morphological features such as the presence of a round shape, heterogeneity within the lymph node and/or irregularity of the borders of the lymph node due to capsular penetration by malignancy

Lymph node status The overall accuracy of N-staging is low but the preferred examination for nodal staging MRI is FNA is not recommended for nodal staging FDG/PET has shown disappointing results for N- staging in rectal cancer, especially in the mesorectum in the presence of a bulky tumour

Two more relavant information. Tumor location MRI is accurate in measuring the distance between the ano-rectal junction and the distal part of the tumor; is accurate for the tumor length Sphinteric infiltration MRI is reliable in assessing sphinteric infiltration, is the preferred method

122 of 374 patients followed up in the MERCURY study were defined as good prognosis stage III or less on MRI The routine policy was primary surgery alone in MRI-predicted stage I, II and in MRI good prognosis stage III Results: 5y-OS: 68% 5y-DFS: 85% LR: 3%

Scenario of ongoing research supported by the multimodal imaging Radiotherapy intensification Dose escalation Treatment de-intensification No surgery for complete clinical response?

Radiotherapy intensification Dose escalation

Radiotherapy intensification Dose escalation 3D CRT IMRT

Registration images Multimodality Imaging

Radiotherapy intensification Dose escalation Set-up control before delivery

Treatment de-intensification No surgery for complete clinical response? Neoadjuvant therapy and surgery contributes markedly to poorer functional outcomes and secondary complications The impressive incidence of pcr in recent trials raises the possibility of selecting pts with a ccr atfer preopertive treatment to avoid surgery WATCH AND WAIT POLICY

Treatment de-intensification No surgery for complete clinical response? Collected data show a high recurrence in the first 12 months, patients following the watch and wait approach should be monitored intensively in the first year At present, the evidence supporting this treatment is limited Results from prospective studies and trials using modern imaging techniques will be essential to guide oncologists in the selection of appropriate patients for nonoperative management of rectal cancer after CRT

Grazie per l Attenzione